SOMX Related Earnings News
-
Somaxon Pharmaceuticals, Inc. (SOMX) Misses Q3 EPS by 30c
-
Somaxon (SOMX) Pops Higher; Enters Silenor Settlement, Sees Improved Q2 Sales
-
Somaxon Pharmaceuticals (SOMX) Announces Settlement Agreement of Silenor Patent; Updates Revenues
-
Somaxon Pharmaceuticals, Inc. (SOMX) Reports In-Line Q1 Loss of 4c/Share
-
Somaxon Pharmaceuticals (SOMX) Posts Q4 Loss of 21c/Share, Inline with the Street
-
Somaxon Pharmaceuticals, Inc. (SOMX) Reports Q3 Loss of $0.36,, Sales Fall Short
-
Somaxon Pharmaceuticals, Inc. (SOMX) Posts Q2 EPS Loss of $0.33,
-
Somaxon Pharmaceuticals (SOMX) Misses Q1 Views
-
Somaxon Pharmaceuticals (SOMX) Misses Q4 Views
-
Somaxon Pharma (SOMX) Posts Narrower than Expected Q3 Loss
-
Somaxon (SOMX) Reports Q4 Loss of $0.08
-
Somaxon Pharma (SOMX) Reports Q4 Loss of $0.52, Misses by 3c
-
Somaxon Pharmaceuticals (SOMX) Reports Q3 Loss of $0.56, Misses by 3c
-
Somaxon Pharmaceuticals (SOMX) Reports Q2 Loss of $0.57
-
Somaxon (SOMX) Misses Q1 EPS by 3c
-
Somaxon Pharma (SOMX) Missed By 9c
Back to SOMX Stock Lookup
